Table 5. Efficacy of chemotherapy regimens. Bracketed figures are percentage values.
| Regimen | Best response on CT | Clinical benefit rates | Progression-free survival (months) | ||||
|---|---|---|---|---|---|---|---|
| SD | PR | SD + 3C chemo | PR + 3C chemo | Mean | Median | Interquartile range | |
| Total patients | 31 (36) | 28 (32) | 26 (30) | 19 (22) | 9.6 | 8.0 | 2.9–12.5 |
| Anthracyclines | 9 (36) | 8 (32) | 8 (32) | 6 (24) | 8.4 | 8.0 | 2.6–11.6 |
| Capecitabine | 12 (39) | 10 (32) | 10 (32) | 6 (19) | 11.7 | 9.2 | 3.2–15.8 |
| Taxanes | 8 (38) | 7 (33) | 7 (33) | 4 (19) | 8.8 | 7.8 | 3.0–11.3 |
| Others | 2 (20) | 3 (30) | 1 (10) | 3 (30) | 5.4 | 4.9 | 2.0–9.1 |